Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
As of today (2026-07-22), the Forward Annual Dividend Yield of SOFIVA GENOMICS Co is 0.00%.
As of today (2026-07-22), the Trailing Annual Dividend Yield of SOFIVA GENOMICS Co is 0.88%.
ROCO:6615's Forward Dividend Yield % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 2.17 * Ranked among companies with meaningful Forward Dividend Yield % only.
During the past 12 months, SOFIVA GENOMICS Co's average Dividends Per Share Growth Rate was 50.80% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was -46.90% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was -39.10% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of SOFIVA GENOMICS Co was 9.10% per year. The lowest was -47.80% per year. And the median was -19.25% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
SOFIVA GENOMICS Co (ROCO:6615) Forward Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
SOFIVA GENOMICS Co Forward Dividend Yield % Related Terms
ROCO:6615 vs TMO, DHR, IDXX: Forward Dividend Yield % Comparison
For the Diagnostics & Research subindustry, SOFIVA GENOMICS Co's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SOFIVA GENOMICS Co Forward Dividend Yield % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, SOFIVA GENOMICS Co's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where SOFIVA GENOMICS Co's Forward Dividend Yield % falls into.
What does a Forward Dividend Yield % of 0.00% mean?
SOFIVA GENOMICS Co (ROCO:6615) has a Forward Dividend Yield % of 0.00% as of Jul. 22, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on SOFIVA GENOMICS Co and its competitors. According to the industry distribution chart, SOFIVA GENOMICS Co ranks #999999 out of 61 companies in the Medical Diagnostics & Research industry.
Is SOFIVA GENOMICS Co's Forward Dividend Yield % too high?
SOFIVA GENOMICS Co's current Forward Dividend Yield % is 0.00%. Based on the distribution chart, SOFIVA GENOMICS Co ranks #999999 out of 61 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, SOFIVA GENOMICS Co has a GF Score™ of 68/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does SOFIVA GENOMICS Co's Forward Dividend Yield % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, SOFIVA GENOMICS Co ranks #999999 out of 61 companies for Forward Dividend Yield %. This places SOFIVA GENOMICS Co in the lower half of its industry. The industry median Forward Dividend Yield % is 2.17. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Medical Diagnostics & Research company?
The median Forward Dividend Yield % among Medical Diagnostics & Research companies is 2.17, based on 61 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on SOFIVA GENOMICS Co and its competitors. For the Medical Diagnostics & Research industry, the median Forward Dividend Yield % is 2.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SOFIVA GENOMICS Co's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SOFIVA GENOMICS Co stock overvalued right now?
Based on GuruFocus' analysis, SOFIVA GENOMICS Co (ROCO:6615) is currently considered Fairly Valued. The stock's GF Value™ is NT$30.94, compared to a current price of NT$34.05 — trading 10.1% above its estimated fair value. The current Forward Dividend Yield % is 0.00%. SOFIVA GENOMICS Co's overall GF Score™ is 68/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For SOFIVA GENOMICS Co (ROCO:6615), the current Forward Dividend Yield % is 0.00% as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SOFIVA GENOMICS Co (ROCO:6615) Overvalued in 2026?
Based on GuruFocus' analysis, SOFIVA GENOMICS Co stock appears to be overvalued.
The current stock price of NT$34.05 is trading 10.1% above its estimated GF Value™ of NT$30.94.
GuruFocus considers SOFIVA GENOMICS Co to be Fairly Valued.
Key valuation signals for ROCO:6615:
Forward Dividend Yield %: 0.00%
GF Value™: NT$30.94 vs. price of NT$34.05 (10.1% above fair value)
No single metric tells the full story. See the ROCO:6615 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SOFIVA GENOMICS Co Ltd provides medical diagnostic services. The services offered by the company include Prenatal, Reproductive, Cancer, Precision Medicine, Newborn, and Rare Diseases. Its testing categories include Genetic, Biochemical, and Chromosome. The business items of Sofiva Group are pre-pregnancy, prenatal, and neonatal genetic testing and medical testing, and other service income. Geographically, it generates the vast majority of its revenue from Taiwan.
68GF Score
Get the complete analysis for ROCO:6615
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6615 has been successfully added to your 
